Embase
Improve your biomedical research with the world’s most comprehensive biomedical literature database. More biomedical evidence by searching comprehensive, relevant, and up-to-date biomedical research. Create systematic searches and automate query building using intuitive search forms. Uncover drug-disease relationships and drug-drug interactions, manually curated from deep indexing. The accelerated pace of biomedical research and development demands comprehensive information. You anticipate risk by assessing everything that is known. You track safety to meet regulations. You uncover connections to push innovations. Embase is a unique medical literature database where comprehensive goes beyond content. With Emtree indexing of full-text content and dedicated search terms, you find all relevant and current results. This includes information that may not be uncovered in other databases. Scroll down to find out why regulatory agencies recommend Embase in their best practice guidelines.
Learn more
PubMed
PubMed® comprises more than 35 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher websites. PubMed is a free resource supporting the search and retrieval of biomedical and life sciences literature with the aim of improving health–both globally and personally. The PubMed database contains more than 35 million citations and abstracts of biomedical literature. It does not include full text journal articles; however, links to the full text are often present when available from other sources, such as the publisher's website or PubMed Central (PMC). Citations in PubMed primarily stem from the biomedicine and health fields, and related disciplines such as life sciences, behavioral sciences, chemical sciences, and bioengineering. MEDLINE is the largest component of PubMed and consists primarily of citations from journals selected for MEDLINE.
Learn more
Dialog
Dialog offers a modular, end-to-end pharmacovigilance literature monitoring solution that supports organizations tasked with drug safety reporting by streamlining and automating the entire literature triage process. It provides access to over 140 authoritative scientific and medical literature databases, such as MEDLINE, Embase, and Biosis, standardizing content across sources to ensure consistent precision search, deduplication, and structured XML output. The DialogML engine employs artificial intelligence to rank search results by patient-safety relevance, highlight key safety concepts, and tag references related to ICSRs (Individual Case Safety Reporting), aggregate reports (PBRER, PSUR, DSUR), and safety signals, so reviewers can rapidly identify high-priority articles. The Dialog Alerts Manager simplifies alert creation and management, offering bulk editing, audit trails of search strategy changes, scheduling flexibility, and delivery history tracking.
Learn more
Compier Literature Screening
Compier Literature Screening is an AI-driven platform designed to assist pharmacovigilance professionals in efficiently screening abstracts, full texts, and translated articles to identify patients, authors, events, products, and safety-related information. The platform offers built-in integration with online biomedical databases such as Medline and supports bulk uploading of literature records from sources like Embase, conference presentations, and PDF journals. It performs automated duplicate checks for each literature search and utilizes validated AI models for automatic screening and annotation of entities. Users can configure scalable literature screening workflows tailored to specific requirements and global regulations. The system facilitates communication with third-party vendors to obtain full texts and includes built-in translation capabilities. It also integrates with safety systems, such as Oracle Argus Safety, to transmit ICSR-relevant articles.
Learn more